1-8 of 8
Donald W. Bunjes, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association Between the Hematopoietic Cell Transplantation-Specific Comorbidity Index (CI) and Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

Mohamad Mohty, MD, PhD, Myriam Labopin, Nadezda Basara, Jan J. Cornelissen, MD, PhD, Reza Tabrizi, Claes Malm, M.D., Jose Antonio Pérez Simón, Arnon Nagler, Nicolaus Kroger, Bernard Rio, Rodrigo Martino, MD, Matthias Eder, MD, Karin Bilger, MD, Donald W. Bunjes, MD, PhD, Gérard Socié, MD, Didier Blaise, MD, Emmanuelle Polge, Vanderson Rocha, MDPhD
Journal: Blood
Blood (2009) 114 (22): 650.
https://doi.org/10.1182/blood.V114.22.650.650
Published: 2009
Journal Articles

Comparison of Outcomes for Non-Myeloablative (NMA) and Myeloablative (MA) Conditioning for Adults with Acute Lymphoblastic Leukaemia (ALL) in First and Second Complete Remission (CR): a Center for International Blood and Marrow Transplant Research (CIBMTR) Analyisis.

David I. Marks, MD, PhD, Tao Wang, PhD, Waleska S. Peréz, MPH, Donald W. Bunjes, MD, PhD, John F. DiPersio, MD, PhD, Martin S. Tallman, MD, Daniel J. Weisdorf, MD
Journal: Blood
Blood (2009) 114 (22): 872.
https://doi.org/10.1182/blood.V114.22.872.872
Published: 2009
Journal Articles

Allogeneic Stem Cell Transplantation for Acquired Aplastic Anemia: Better Outcome with Bone Marrow as Compared to Peripheral Blood in HLA-Matched Sibling Donor Transplantation and Improved Outcome Over Time After Matched Unrelated Donor Transplantation. A Retrospective Analysis of Transplants Reported to the German Registry for Stem Cell Transplantation (DRST).

Hubert Schrezenmeier, Ulrike Feldmann, Hellmut Ottinger, Matthias Eder, Monika Führer, Hans-Jochem Kolb, Axel Zander, Karin Kolbe, Dietger Niederwieser, Donald W. Bunjes, MD, PhD, Rainer Schwerdtfeger, MD, Rupert Handgretinger, Karl Welte, Carlheinz Müller, Gerhard Ehninger, Jürgen Finke, Dietrich Beelen
Journal: Blood
Blood (2009) 114 (22): 876.
https://doi.org/10.1182/blood.V114.22.876.876
Published: 2009
Journal Articles

Shift to a New Donor Does Not Improve the Outcome After Second Allogeneic Stem Cell Transplantation (alloSCT) in Acute Leukemia Relapse After a First Allosct – a Risk Factor Analysis by the German Stem Cell Registry (DRST).

Maximilian Christopeit, MD, Ulrike Feldmann, Juergen Finke, Donald W. Bunjes, MD, PhD, Dietrich W. Beelen, Martin Bornhaeuser, Christoph Faul, MD, Rainer Schwerdtfeger, MD, Hans-Jochem Kolb, MD, Martin Gramatzki, Hans Martin, MD, Stefan O Schoenland, Christof Scheid, Lutz Uharek, Axel R. Zander, Arnold Ganser, MD, Guido Kobbe, MD, Ernst Holler, PhD, Axel A Fauser, Joachim Kienast, Hermann Einsele, Herbert G. Sayer, MD, PhD, Ralph Mayer, MD, Gerhard Behre, MD, Hellmut Ottinger, Hubert Schrezenmeier, Christoph Schmid
Journal: Blood
Blood (2009) 114 (22): 3328.
https://doi.org/10.1182/blood.V114.22.3328.3328
Published: 2009
Journal Articles

Mobilized Peripheral Blood Stem Cells (PBSC) Compared with Bone Marrow (BM) as the Stem Cell Source for Unrelated Donor Allogeneic Transplantation with Reduced Intensity Conditioning (RIC-alloSCT) in Patients with Acute Myeloid Leukemia (AML) in Complete Remission (CR): a Retrospective Analysis From the ALWP of EBMT.

Arnon Nagler, Myriam Labopin, Avichai Shimoni, Dietger Niederwieser, Nadezda Basara, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Axel R. Zander, Renate Arnold, MD, Hildegard Greinix, Jan J. Cornelissen, MD, PhD, Graham H Jackson, MD, Charles Craddock, BM, DPhil, FRCP, FRCPath, Donald W. Bunjes, MD, PhD, Arnold Ganser, MD, Nigel H. Russell, MD, Slawomira Kyrcz-Krzemien, Mohamad Mohty, MD, PhD, Vanderson Rocha, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 527.
https://doi.org/10.1182/blood.V114.22.527.527
Published: 2009
Journal Articles

Allogeneic Hematopoietic Cell Transplantation Can Cure Some Patients with Acute Leukemia in Relapse or Primary Induction Failure: A CIBMTR Study.

Michel Duval, MD, Wensheng He, MS, John P. Klein, PhD, Martin S. Tallman, MD, John F. DiPersio, MD, PhD, Donald W. Bunjes, MD, PhD, Daniel J. Weisdorf, MD
Journal: Blood
Blood (2009) 114 (22): 528.
https://doi.org/10.1182/blood.V114.22.528.528
Published: 2009
Journal Articles

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia with Normal Karyotype: A Risk Factor Analysis in 247 Patients, Based On Molecular Markers and Stage at Transplantation.

Tim Pfeiffer, Michael Schleuning, Matthias Eder, MD, Johanna Tischer, MD, Jan Braess, Donald W. Bunjes, MD, PhD, Hildegard Greinix, MD, Gesine Bug, MD, Ernst Holler, PhD, Daniel V Oruzio, Marta Krejci, Christof Scheid, Armin Gerbitz, MD, Karin Kolbe, Ralf G Meyer, Renate Arnold, MD, Maximilian Christopeit, MD, Herrad Baurmann, Stephanie v. Harsdorf, Wolfgang Andreas Bethge, MD, Elke Dammann, Margarete Rothmayer, Anne Franke, Susanne Schnittger, PhD, Jiri Mayer, MD, Günther Schlimok, Rainer Schwerdtfeger, Arnold Ganser, Hans Jochem Kolb, Christoph Schmid
Journal: Blood
Blood (2009) 114 (22): 1209.
https://doi.org/10.1182/blood.V114.22.1209.1209
Published: 2009
Journal Articles

Comparison of Outcomes After Allogeneic HSCT for Adult Patients with AML in Remission Using in the Conditioning Regimen Either I.V. Busulfex (BU) Plus Cyclophosphamide (Cy) or TBI Plus Cy: An- ALWP-EBMT Survey.

Arnon Nagler, MD, Myriam Labopin, Avichai Shimoni, Liisa Volin, Donald W. Bunjes, MD, PhD, Anne Huynh, Agnes Buzyn, Alessandro Rambaldi, Vanderson Rocha, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 195.
https://doi.org/10.1182/blood.V114.22.195.195
Published: 2009